|
 |
KytrilThis page contains recent news articles, when available, and an overview of Kytril but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Researchers from Japan have reported that the combination of Aloxi® (palonosetron) and dexamethasone was as effective as Kytril® (granisetron) and Cancer Consultants Attempt to legalize marijuana for medical use fails again - Mar 13, 2009 ..."In my opinion the drugs we have such as Zofran and Kytril, they do a wonderful job of controlling nausea," Kurth said. "I don't see great strides in using Le Mars Daily Sentinel Spectrum Pharmaceuticals Strengthens Management, Realigns ... - Feb 25, 2009 ...oral chemotherapeutic agent for the treatment of metastatic breast cancer, and KYTRIL(R), an anti-nausea agent used in combination with oncolytics. MarketWatch (press release) How dangerous is Marijuana? - Jan 18, 2009 This includes 196 deaths caused by taking anti emetics (Compazine, Reglan, Marinol, Zofran, Anzemet, Kytril, Tigan), 118 for taking anti-spasmodics Denver Post, Novo fármaco mais efectivo na prevenção de vómitos devido a ... - Jan 12, 2009 é comparável ao antigo agente, o granissetrom (comercalizado como Kytril ou em diversas versões genéricas), na prevenção dos vómitos na fase imediata, Farmacia, Squashing a Queasy StomachHow to avoid nausea and vomiting during ... - Dec 23, 2008 The regimen includes a 5-HT3 antagonist—Anzemet (dolasetron), Kytril/Sancuso (granisetron), Zofran (ondansetron), or Aloxi (palonosetron)—given before Curetoday.com (press release), FDA Approves Patch To Relieve Chemo-Induced Nausea - 16 Sep 2008 Granisetron, delivered by injection or orally via tablets or solution, is sold under the brand name Kytril by Roche Pharmaceuticals. AHN Podcast: Managing nausea and vomiting during chemotherapy - Sep 13, 2008 The brand names for those, respectively, are Zofran, Kytril, Anzemet and Aloxi, and those will decrease nausea and vomiting quite a bit. MayoClinic.com APP Pharmaceuticals Receives Final Approval for Nausea Drug - Jul 11, 2008 APP Pharmaceuticals has received final approval from the FDA for its ANDA to market a generic version of Roche’s Kytril in 1-mg/mL, 1-mL single-dose and FDA news (subscription), Teva Introduces Granisetron Hydrochloride Injection in Multiple ... - Jul 1, 2008 ...product is AP rated to Kytril®* Injection. With the addition of this new size, Teva now offers Granisetron Hydrochloride Injection in 0.1 mg/mL, 1 mL vials, PharmaLive.com (press release), State Receives More Money From GlaxoSmithKline Settlement - Jun 13, 2008 ...$145 million in damages and penalties to Medicaid programs across the country to settle such allegations with respect to its drugs Zofran and Kytril. NJBIZ, Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share ... - May 8, 2008 During the quarter, we expanded our other generic US product portfolio with the launch of generic versions of Fosamax(R) and Kytril(R) and continued to Earthtimes (press release), Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share ... - May 8, 2008 During the quarter, we expanded our other generic US product portfolio with the launch of generic versions of Fosamax(R) and Kytril(R) and continued to SunHerald.com, Roche sales drop 4% on currency, Tamiflu hit - Apr 17, 2008 The company was hurt by copycat versions of chemotherapy medication Kytril and impact of last year's European Commission suspension of HIV drug Viracept, MarketWatch Oxford Biomedica Announces Board Changes - Apr 15, 2008 ...for pancreatic cancer (peak sales >US$1 billion), Humalog® for diabetes (peak sales >US$1 billion) and Kytril® for emesis (peak sales >US$0.5 billion). PharmaLive.com (press release), NeurAxon Announces the Appointment of David Brand to Its Board of ... - 11 Mar 2008 He led the launch activities for Paxil and Kytril and well as numerous in-licensing, co-promotion, and co-development partnerships. Earthtimes, India's Cipla gets FDA nod for granisetron HCL - Mar 3, 2008 The drug, a generic version of Roche Laboratories Inc's Kytril tablets, is indicated for prevention of nausea and vomiting caused by chemotherapy and Reuters UPDATE 1-Eisai nausea drug gets US additional use approval - Mar 3, 2008 VX: Quote, Profile, Research) Kytril, which are now off-patent, as well as Sanofi-Aventis's (SASY.PA: Quote, Profile, Research) Anzemet. Reuters Orchid gets USFDA nod for non-antibiotic drug - Feb 13, 2008 Granisetron hydrochloride, known by the brand Kytril of drug major Roche, is used in the treatment of side effects like nausea related to chemotherapy. Business Standard, Orchid receives two US FDA approvals - Mar 9, 2008 It is sold in the brand name Kytril as injection, tablets and oral solution. "Including Orchid, there are about six players in India engaged in this generic Express Pharma, Mylan Gets FDA OK to Sell Generic Kytril - Feb 1, 2008 The US Food and Drug Administration approved Mylan's abbreviated new drug application for granisetron hydrochloride tablets, also known as Kytril, Forbes, FDA Backs Teva's Generic Kytril Exclusivity - Jan 30, 2008 The FDA has agreed with Teva Parenteral Medicines’ position that the company is entitled to 180-day exclusivity for generic Kytril 1-mg/1-mL single-dose FDA news (subscription), Mylan receives final FDA approval for nausea treatment - Feb 1, 2008 The product is a generic version of Roche's Kytril Tablets, the Pittsburgh-based pharmaceutical company said, adding it will begin shipping the tablets Forbes, Mylan Pharmaceuticals Inc reports final approval for Granisetron ... - Feb 4, 2008 Granisetron Hydrochloride Tablets are reportedly the generic version of Roche's Kytril Tablets, which had US sales of around USD89m for the 12 months ending Trading Markets (press release), Mylan Announces Final FDA Approval for Granisetron Hydrochloride ... - Feb 1, 2008 Granisetron Hydrochloride Tablets are the generic version of Roche's Kytril Tablets, which had US sales of approximately $89 million for the 12 months CNNMoney.com Mylan Receives FDA Approval For Its ANDA For Granisetron ... - Feb 1, 2008 The Canonsburg, Pennsylvania-based Company, said Granisetron Hydrochloride Tablets are the generic version of Roche's Kytril Tablets and would be shipped RTT News, Business News Briefs - Feb 1, 2008 Mylan Inc. said it received approval from the Food and Drug Administration to market the generic version of Roche's Kytril tablets. Pittsburgh Post Gazette, Mylan Receives Final FDA Approval For Granisetron Hydrochloride ... - Feb 1, 2008 Mylan noted that Granisetron Hydrochloride Tablets are the generic version of Roche's Kytril Tablets. The company said that this product had US sales of Trading Markets (press release), APP Pharmaceuticals Launches Granisetron Hydrochloride Injection, USP - Jan 17, 2008 ...has launched Granisetron Hydrochloride Injection, 0.1 mg/mL, 1 mL single dose vials, the generic equivalent of Hoffmann-LaRoche's Kytril(R) Injection. PR-Inside.com (Pressemitteilung), Businessnetwire.us: Morning News To Focus On For January 18, 2008 - Jan 18, 2008 Kytril Injection is a registered trademark of Hoffman-LaRoche Inc. PAR Technology Corporation (NYSE: PTC) PAR Technology Corporation closed at $6.47 Manufacturing Business Technology, STMicroelectronics Accepts 91% Of Genesis Shares [STM] - Jan 17, 2008 ...the company stated that it has launched Granisetron Hydrochloride Injection, the generic equivalent of Hoffmann-LaRoche's Kytril Injection. RTT News, Texas AG nabs another Big Pharma payment over pricing - Nov 20, 2007 The settlement charged that glaxosmithkline overstated the market value of Kytril, Zofran and Amoxil to the Texas Medicaid program. Legal News Line, Capital Highlights A summary of the week's significant events in ... - Nov 20, 2007 16 agreed to repay the state of Texas almost $1.4 million for charging the state inflated prices for the prescription drugs Kytril, Zofran and Amoxil from Jasper Newsboy, Around the region - 17 Nov 2007 London-based Glaxo charged "inflated prices" for the anti-nausea drugs Kytril and Zofran and the antibiotic Amoxil from 1994 to 2002, Texas Attorney General Houston Chronicle, Can Champ Aloxi Be Toppled In CINV Market? Answer Soon - 17 Nov 2007 Granisetron, sold under the brand name Kytril in oral and intravenous forms by F. Hoffmann-La Roche Inc., also is the active ingredient in the transdermal BioWorld Online, Medicaid fraud case settled - Nov 16, 2007 The defendants reported inflated prices for anti-emetic drugs called Kytril and Zofran and an antibiotic, Amoxil. The Medicaid program reimbursed pharmacies Bizjournals.com, Antiemetics, Their Function, and Their Role in Controlling ... - Oct 18, 2007 The 5-HT3 antagonists commonly used are dolasetron (commercially Anzemet), granisetron (Kytril), ondansetron (Zofran), tropisetron (Navoban), Cancer Focus, �页�调色版 - Sep 17, 2007 ...and was appointed Business Unit Head for Gastrointestinal and Central Nervous System Products, where he led the launch activities for Paxil? and Kytril? 金�界, Scottish firm targets South Korea for cancer patch - Aug 13, 2007 The Scottish firm has developed a transdermal delivery system for the anti-emetic granisetron, the active ingredient in Roche's Kytril, formulated in a DrugResearcher.com, Roche's Tarceva(R) Delivers Longer Life for Lung Cancer Patients - Sep 4, 2007 ...hypercalcaemia of malignancy), Kytril (for chemotherapy and radiotherapy-induced nausea and vomiting), Neupogen (for cancer-related neutropenia), PR Newswire Brasil (liberação de imprensa), MGI Pharma’s Aloxi could get broader label for post-operative ... - Jul 30, 2007 Financial Times,...to the other approved 5HT3 antagonists like Anzemet (dolasetron), from the French firm Aventis, and Kytril (granisetron), from the Swiss company Roche. Agents used at risk rs knowledge shown. - Jun 18, 2007 Journal lycéen,Estimated heritability carefully follow hydrodiuril harsh impact kytril that paid leflunomide quarantine. The travel provide and lescol simply because Aerosols are classified as mask when shown. - Jun 19, 2007 Journal lycéen,Estimated heritability assess the kytril far superior leflunomide proven cases lescol followed. The travel surgery for levbid cases of levonorgestrel The absence scientists and showed large lower. - Jul 1, 2007 Gazeta Lubuska,Soria et results in testify in kytril had close monitoring. Those suspect the authors through conflict exposure. Newly discovered her husband cover only Carbon OKs action over prescriptions - 25 May 2007 Allentown Morning Call,The allegedly overpriced drugs named in the lawsuit are Zofran injections and tablets and Kytril injections and tablets, all of which are used to prevent UPDATE 1-Barr Pharma unit gets tentative OK for Kytril tablets - 18 Jan 2007 ReutersVX: Quote, Profile , Research) Kytril tablets, and its shares rose nearly 4 percent. The company expects to receive final approval from the US Food and Drug Rheologics Establishes Scientific Advisory Board - Dec 7, 2006 Genetic Engineering News (press release),...number of capacities in sales (RMA), product management (Tagamet(R), Hycamtin(R)) and new product development (Kytril(R), Androderm(R), Argatroban(R)). Rheologics Establishes Scientific Advisory Board - Dec 7, 2006 Market Wire (press release)...product management (Tagamet®, Hycamtin®) and new product development (Kytril®, Androderm®, Argatroban®). Prior to joining the pharmaceutical industry, Speaking of generics Oct 25, 2006 Fosamax, Feb. 2008. Geodon, Sept. 2007. Glyset, July 2009. Imitrex, June 2007. Kytril, June 2008. Lamictal, Jan. 2009. Lotrel, Jan. 2007. Mavik, Dec. 2007. ... -Monterey County Herald, Publicado: Sab Oct 14, 2006 5:01 pm Asunto: Unless directed to do ... Oct 14, 2006 My grandmother and my aunt are herbalists and kytril y mom dabbled in it, so Id grown up learning about the prope l ties of different herbs, and Id done some ... -Shell Security, Enzo Biochem Appoints Gary C. Cupit, Former Novartis ... Oct 16, 2006 Pharmaceuticals in a number of sales capacities (RMA), product management (Tagamet®, Hycamtin®) and new product development (Kytril®, Androderm®, Argatroban ... -Business Wire (press release), Enzo Biochem Appoints Gary C. Cupit, Former Novartis ... Oct 16, 2006 Beecham Pharmaceuticals in a number of sales capacities (RMA), product management (Tagamet(R), Hycamtin(R)) and new product development (Kytril(R), Androderm(R ... -PharmaLive.com (press release), Med firm to refund $70M in overcharges Sep 12, 2006 Between 1 million and 5 million cancer patients nationwide who used the drugs Kytril and Zofran since 1991 will potentially be eligible for refunds, said Renee ... -MetroWest Daily News BUSINESS BRIEFS: BRIEFS Sep 12, 2006 Glaxo engaged in a scheme to inflate the price of Zofran and Kytril for the Medicare and Medicaid programs, which reimburse health care providers based on the ... -Asbury Park Press Glaxo SmithKline settles pricing case Sep 15, 2006 The conduct at issue concerned Glaxo’s reporting of wholesale price data for two of its drugs, Kytril and Zofran, injectable anti-nausea drugs used in ... -Nashua Telegraph (subscription) New Jersey : New Jersey Receives Medicaid Fraud Civil Settlement ... Sep 12, 2006 ...initiated when a federal false claims lawsuit was filed alleging that Glaxo SmithKline inflated the average wholesale price for Zofran and Kytril, which are ... -All American Patriots Mo. receives $235,757 Medicaid fraud settlement from ... Sep 1, 2006 ...federal government, resolved concerns that GSK improperly inflated the prices it reported that drug purchasers paid for the injectable drugs Kytril and Zofran ... -Bizjournals.com hw2;Settlement reached with drug maker Sep 2, 2006 GlaxoSmithKline was alleged to have improperly inflated the average wholesale price for Kytril and Zofran, two injectible anti-nausea drugs used in connection ... -BurlingtonFreePress.com Former Chiron Exec Joins APT Pharmaceuticals as CEO Sep 6, 2006 He has played important roles in the development and approval of numerous drugs including Kytril(R), Requip(R), Kredex(R), Paxil CR(R), Cathflo(R) Activase(R ... -Business Wire Ohio to get $541K in settlement with GlaxoSmithKline Aug 15, 2006 According to government allegations, Glaxo increased the reported prices for two anti-nausea drugs used in connection with chemotherapy, Kytril and Zofran, to ... -Charlotte Business Journal GlaxoSmithKline settles overcharging case for $70 million Aug 10, 2006 The case was settled for patients on two GSK drugs, Kytril and Zofran. The drugs are commonly used to counter the side effects of cancer treatments. ... -Raw Story Prescription Drugs | GlaxoSmithKline To Pay $70M To Settle ... Aug 11, 2006 The settlement pertains to injectable antinausea drugs Kytril and Zofran, which are given to cancer patients undergoing chemotherapy, as well as to the ... -Kaiser network.org GlaxoSmithKline settles $91m suit Aug 10, 2006 ...settlement will provide restitution to consumers who suffered from a "decade-long company scheme to inflate the price of two cancer drugs", Zofran and Kytril. ... -The Australian Landmark Settlement Could Signal the End of Prescription Drug ... Aug 10, 2006 ...will pay $70 million in a nationwide class-action settlement to cancer patients and health plans who were overcharged for vital medications Kytril and Zofran. ... -U.S. Newswire GlaxoSmithKline to Pay $70 Million to End Drug Suits (Update3) Aug 10, 2006 ...health program for the elderly and disabled, has moved away from AWP-linked payments for drugs administered in doctors offices, such Glaxo's Kytril and Zofran ... -Bloomberg Attorney General: Kan. to Receive $58,065 in Glaxo SmithKline ... Aug 17, 2006 ...issue concerned Glaxo's reporting of bench mark pricing data that was used by Medicare and Medicaid to set reimbursement amounts for its drugs Kytril and Zofran ... -Insurance Journal GlaxoSmithKline in US cancer drug settlement Aug 10, 2006 Connecticut, New York, Nevada, Montana and Arizona who suffered from a "decade long company scheme to inflate the price of two cancer drugs," Zofran and Kytril ... -Reuters GlaxoSmithKline to Pay $70 Million to End Drug Suits (Update1) Aug 10, 2006 New York's Medicaid program will get $1.5 million as restitution for inflated prices for two chemotherapy drugs, Kytril and Zofran, and an antibiotic, Amoxil. ... -Bloomberg Glaxo pays $70m to end price row Aug 10, 2006 The lawsuits stem from claims that Glaxo used illegal schemes to inflate the price of drugs - including cancer treatments Zofran and Kytril - costing consumers ... -BBC News Glaxo will settle suits by paying $70 million Aug 11, 2006 New York's Medicaid program will get $1.5 million as restitution for inflated prices of Kytril and Zofran, injectable antinausea drugs used in connection with ... -Philadelphia Inquirer Glaxo Settles on Illegal Drug Pricing Charge Aug 11, 2006 ...that the Research Triangle, NC-based company had essentially indicated to doctors and hospitals that it was willing to supply its drugs, Kytril and Zofran, for ... -Brandweek Magazine GlaxoSmithKline Settles Illegal Pricing Scheme Aug 11, 2006 GSK will pay the New York Medicaid program a total of $1.53 million in restitution for inflating the prices of three specific drugs -- Kytril and Zofran ... -Consumer Affairs : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |